In this asset deal, a group of private investors has acquired Saneca's cosmetic products portfolio and its pharmaceutical manufacturing plant in Slovakia, from Sanofi. Financial terms of this transaction have not been disclosed.
Saneca (originally Zentiva Hlohovec) is a pharmaceutical contract manufacturing company active in the development, production, registration and distribution of generic medicines and active pharmaceutical ingredients. Saneca also owns portfolio of cosmetic and generic products.
Sanofi is a global integrated healthcare leader engaged in the research, development, manufacturing and marketing of therapeutic solutions.
Oaklins' team in Slovakia advised the buyer in this transaction. The process included due diligence, valuation, negotiation of transaction terms, and selection of new management in the newly purchased entity.
© 2018 Oaklins. All rights reserved. Oaklins is the collective trade name of independent member firms affiliated with Oaklins International Inc. For details of the nature of affiliation, please refer to www.oaklins.com/legal.